Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Michael Polansky has a new, skin-focused biotech. Don’t call it a drug company.

Though its data could be useful for pharmaceutical firms, Polansky’s latest entrepreneurial endeavor, Outer Bio, is serious about steering clear of road bumps that slow biotechs.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Health & Medicine

The next global health architecture must deliver more than reform

After months of speculation, prospective candidates in the race to become the next Director-General of the World Health Organization (WHO) are now emerging. At the same time, member states have launched a process to review the global health architecture, with the aim of clarifying roles, strengthening coordination, and aligning financing…

More from Thursday 27 August →